Prostate-Specific Antigen (PSA) Test - NCI - National Cancer Institute
The PSA test is used to monitor men after surgery or radiation therapy for prostate cancer to see if their cancer has recurred (come back). If a man’s PSA level begins to rise after prostate …
Understanding Prostate Changes - NCI - National Cancer Institute
2024年5月8日 · Learn about prostate changes and symptoms that are not cancer, plus risk factors and treatment for prostatitis, enlarged prostate (BPH), prostate cancer. Talk with your doctor …
Definition of PSA - NCI Dictionary of Cancer Terms
A protein made by the prostate gland and found in the blood. PSA blood levels may be higher than normal in men who have prostate cancer, benign prostatic hyperplasia (BPH), or infection …
Prostate Cancer Treatment - NCI - National Cancer Institute
2023年2月16日 · PSA is a substance made by the prostate that may be found in higher than normal amounts in the blood of men who have prostate cancer. PSA levels may also be high …
Xtandi Approved for High-Risk Prostate Cancer - NCI
2024年1月5日 · When the PSA doubling time is rapid, around 9 months or less, studies have suggested it means those patients are at high-risk of having their cancer spread to other …
FDA Approves Relugolix for Advanced Prostate Cancer
2021年1月26日 · Reducing the production of testosterone to very low levels with drugs is often called medical (or chemical) castration, because it achieves the same results as surgical …
Drugs Approved for Prostate Cancer - NCI - National Cancer …
2024年10月9日 · This page lists cancer drugs approved by the Food and Drug Administration (FDA) for prostate cancer. The list includes generic names and brand names.
Hormone Therapy for Prostate Cancer Fact Sheet - NCI
Hormone therapy is standard treatment for those who have a symptomatic recurrence (as documented by CT, MRI, PSMA PET scan, or bone scan) and may also be recommended for …
Prostate Cancer Treatment (PDQ®) - NCI - National Cancer Institute
After radical prostatectomy, a detectable PSA level identifies patients at elevated risk of local treatment failure or metastatic disease; however, a substantial proportion of patients with an …
Prostate Cancer Screening | Cancer Trends Progress Report
Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland. The PSA test measures the level of PSA in a man’s blood. For this test, a …